(Q39527913)

12 September 2017

title

Loss of EGFR induced autophagy sensitizes hormone refractory prostate cancer cells to adriamycin (English)

1 reference

12 September 2017

0 references

1 reference

Shuping Xu

1

1 reference

12 September 2017

Zhang Weihua

series ordinal

2

1 reference

12 September 2017

publication date

12 January 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

71

1 reference

12 September 2017

issue

11

1 reference

12 September 2017

page(s)

1216-1224

1 reference

Targeting epidermal growth factor receptor: novel therapeutics in the management of cancer

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Epithelial phenotypes in the developing human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Expression patterns of potential therapeutic targets in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Epidermal growth factor-related peptides and the epidermal growth factor receptor in normal and malignant prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

A phase II trial of docetaxel and erlotinib as first-line therapy for elderly patients with androgen-independent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Ligand- and kinase activity-independent cell survival mediated by the epidermal growth factor receptor expressed in 32D cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Suppression of EGFR expression by antisense or small interference RNA inhibits U251 glioma cell growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Small interfering RNAs suppress the expression of endogenous and GFP-fused epidermal growth factor receptor (erbB1) and induce apoptosis in erbB1-overexpressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Combining siRNAs at two different sites in the EGFR to suppress its expression, induce apoptosis, and enhance 5-fluorouracil sensitivity of colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Targeting epidermal growth factor receptor--are we missing the mark?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

The mouse waved-2 phenotype results from a point mutation in the EGF receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Survival of cancer cells is maintained by EGFR independent of its kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

The double-edged sword of autophagy modulation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Hypoxia-induced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Autophagy-inducing agents augment the antitumor effect of telerase-selve oncolytic adenovirus OBP-405 on glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Methods for monitoring autophagy using GFP-LC3 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Randomized phase II study of two doses of gefitinib in hormone-refractory prostate cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Results from a monocentric phase II trial of erlotinib in patients with metastatic prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

A phase II trial of gefitinib in patients with non-metastatic hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Epidermal growth factor receptor activation in androgen-independent but not androgen-stimulated growth of human prostatic carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Combining EGFR inhibitors with radiation or chemotherapy: will preclinical studies predict clinical results?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

EGF activates an inducible survival response via the RAS-> Erk-1/2 pathway to counteract interferon-alpha-mediated apoptosis in epidermoid cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Epidermal growth factor (EGF) suppresses staurosporine-induced apoptosis by inducing mcl-1 via the mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Radiosensitivity of tumor cell lines after pretreatment with the EGFR tyrosine kinase inhibitor ZD1839 (Iressa).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Role of epidermal growth factor receptor degradation in gemcitabine-mediated cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Taxanes: microtubule and centrosome targets, and cell cycle dependent mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Differential effects of cell cycle regulatory protein p21(WAF1/Cip1) on apoptosis and sensitivity to cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

Hypoxia and the metabolic phenotype of prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

The DU145 human prostate carcinoma cell line harbors a temperature-sensitive allele of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

The role of p53 in glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROS.21337

21 January 2018

Identifiers

DOI

10.1002/PROS.21337

1 reference

release_rx5nbhvbs5b27gvhor2aeae3sy

12 September 2017

Fatcat ID

0 references

1 reference